Ubiquitech Software Corp. (UBQU) Stock Price & Analysis
Educational signal · not a buy or sell recommendation · How to read this
P/E 12.00 means the share price is 12.00 times one year of earnings per share. Market cap $3.18M is the value of all shares combined.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 17, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerUbiquitech Software Corp. (UBQU) trades at $0.0001. Ubiquitech Software Corp. develops Internet marketing and sales software solutions, including advertising platforms and lead generation portals. Market cap: $3.18M, Sector: Healthcare.
Price as of · Last analyzed: Mar 17, 2026Analyst Coverage for UBQU: UBQU does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
Ubiquitech Software Corp. (UBQU) Healthcare & Pipeline Overview
Ubiquitech Software Corp. operates in the healthcare sector, providing Internet marketing and sales software solutions. Its offerings include advertising platforms, lead generation portals, and social networks designed to enhance sales and customer engagement, primarily serving currency trading, hedge funds, and asset management industries.
What Is the Investment Thesis for UBQU?
Ubiquitech Software Corp. presents a speculative investment opportunity given its presence in the OTC market and its focus on Internet marketing and sales software solutions. With a market capitalization of $3.18M and a negative P/E ratio of -18.92, the company's financial performance indicates challenges in profitability. The negative beta of -6.13 suggests an inverse correlation with the market, which could offer diversification benefits. Growth catalysts may include the expansion of its Blue Crush Monetization System and the potential for increased adoption of its lead generation portal, InternationalFortune.com. However, investors should be aware of the risks associated with OTC-listed companies, including limited liquidity and disclosure requirements.
Based on FMP financials and quantitative analysis
UBQU Key Highlights
Market Cap of $3.18M indicates the company is a micro-cap stock with limited liquidity.
- P/E Ratio of -18.92 reflects the company's current lack of profitability.
- Profit Margin of -13.9% highlights the challenges in achieving sustainable profitability.
- Gross Margin of 23.1% suggests some efficiency in core operations despite overall losses.
- Beta of -6.13 indicates an inverse correlation with the market, potentially offering diversification benefits.
Who Are UBQU's Competitors?
UBQU is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| BIOE Bio Essence Corporation | $0.18 | 0.00% | $7.21M | — |
| SNOA Sonoma Pharmaceuticals, Inc. | $1.24 | -0.80% | $5.94M | — |
| BFRI Biofrontera Inc. | $1.01 | -2.40% | $13.0M | — |
| COSM COSM | $0.38 | -1.58% | $20.7M | — |
| QNTM Quantum BioPharma Ltd. | $3.44 | +0.44% | $22.0M | — |
| AYTU Aytu BioPharma, Inc. | $2.07 | -0.96% | $22.2M | — |
| TXMD TherapeuticsMD, Inc. | $2.05 | +0.99% | $23.7M | — |
| CPHI CPHI | $0.66 | +0.61% | $26.6M | — |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are UBQU's Key Strengths?
Proprietary software solutions.
- Established lead generation portal.
- Social network platform.
- Focus on niche markets.
What Are UBQU's Weaknesses?
Limited market capitalization.
- Negative profitability.
- Dependence on specific software solutions.
- OTC market listing.
What Are the Key Risks for UBQU?
Negative return on equity (-29.1%) — the business is not currently generating profit on shareholder capital.
- Limited liquidity in the OTC market.
- Negative profitability and financial challenges.
- Intense competition in the software and marketing space.
- Technological obsolescence of existing software solutions.
What Threats Does UBQU Face?
- Intense competition.
- Technological obsolescence.
- Regulatory changes.
- Economic downturn.
What Are UBQU's Competitive Advantages?
- Proprietary Blue Crush Monetization System.
- Established lead generation portal (InternationalFortune.com).
- Social network platform (Blue Crush Connect).
- Focus on niche markets within healthcare and finance.
What Does UBQU Do?
Ubiquitech Software Corp., founded in 2007 and based in Denver, Colorado, develops and markets Internet-based software solutions. The company's primary focus is on creating platforms that enhance online advertising and lead generation. Its flagship product, the Blue Crush Monetization System, aims to improve existing advertising platforms to drive sales. Additionally, InternationalFortune.com serves as a lead generation portal, targeting currency trading companies, hedge funds, and other asset managers globally. Blue Crush Connect, another key offering, functions as a social network designed to reward and incentivize customers. Ubiquitech also operates AffiliateCashExpress.com and NeedFunded.com, expanding its reach in the online marketing space. While classified in the Drug Manufacturers - Specialty & Generic industry, its core business revolves around software and internet marketing solutions, serving a diverse range of clients seeking to optimize their online presence and customer engagement.
What Products and Services Does UBQU Offer?
- Develops Internet marketing software solutions.
- Creates advertising platforms to improve sales.
- Operates lead generation portals for financial companies.
- Provides social networks to reward and incentivize customers.
- Offers solutions for currency trading companies and hedge funds.
- Aims to enhance online presence and customer engagement.
How Does UBQU Make Money?
- Generates revenue through software licensing fees.
- Offers advertising platform services to clients.
- Provides lead generation services to financial institutions.
- Operates social networks with monetization strategies.
What Industry Does UBQU Operate In?
Ubiquitech Software Corp. operates within the broader healthcare sector but focuses on providing Internet marketing and sales software solutions. The market for digital marketing tools in the healthcare industry is growing, driven by the need for companies to enhance their online presence and customer engagement. However, the competitive landscape includes established players in the software and marketing space, as well as specialized firms catering to the healthcare sector. Ubiquitech's success depends on its ability to differentiate its offerings and effectively target its niche markets within the healthcare and financial services industries.
Who Are UBQU's Key Customers?
- Currency trading companies
- Hedge funds
- Asset managers
- Businesses seeking online advertising solutions
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● No usable price
- ● No filing on record
- ● No analyst coverage
Financial Health
Ubiquitech Software Corp.'s Piotroski F-Score is 7/9, a 9-point checklist of profitability, leverage and efficiency — signaling solid underlying fundamentals.
UBQU Valuation & Market Position
With a $3.18M market cap, Ubiquitech Software Corp. sits in the micro-cap segment of the market.
Key Financial Metrics
Return on equity for Ubiquitech Software Corp. stands at -29.1%, a gauge of how efficiently it converts shareholder capital into profit. UBQU trades at a trailing price-to-earnings ratio of 12.00, below the Healthcare sector average of ~21.10x. Its free cash flow yield is 57.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.00 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is 8.3%, the inverse of the P/E and a quick read on earnings relative to price.
Company Profile
Ubiquitech Software Corp. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Denver, United States.
UBQU Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
UBQU Latest News
-
Stocks That Hit 52-Week Lows On Thursday
· Feb 27, 2020
-
Stocks That Hit 52-Week Lows On Wednesday
· Feb 12, 2020
-
Stocks That Hit 52-Week Lows On Tuesday
· Dec 10, 2019
-
Stocks That Hit 52-Week Lows On Wednesday
· Dec 4, 2019
UBQU Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for UBQU.
Price Targets
Wall Street price target analysis for UBQU.
UBQU MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for UBQU; grades run from A+ (80-100) to F (below 30).
Leadership: James Andrew Ballas
CEO
James Andrew Ballas serves as the CEO of Ubiquitech Software Corp. His background includes experience in managing teams and overseeing the development and marketing of Internet-based software solutions. He has been involved in the company's strategic direction and product development efforts since its inception. His leadership is focused on driving growth through innovation and strategic partnerships.
Track Record: Under James Andrew Ballas's leadership, Ubiquitech Software Corp. has developed and launched several Internet marketing and sales software solutions, including the Blue Crush Monetization System and InternationalFortune.com. He has overseen the company's efforts to expand its market reach and attract new clients. However, the company's financial performance has been challenged by profitability issues.
UBQU OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Ubiquitech Software Corp. may not meet the minimum financial standards or disclosure requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited information available to investors, and trading activity can be sporadic. Investing in OTC Other stocks carries higher risks due to the lack of regulatory oversight and transparency compared to NYSE or NASDAQ-listed companies.
- OTC Tier: OTC Other
- Limited liquidity and trading volume.
- Lack of regulatory oversight and transparency.
- Potential for price manipulation.
- Higher risk of fraud or misrepresentation.
- Limited availability of financial information.
- Verify the company's registration and legal status.
- Review available financial statements and disclosures.
- Assess the company's business model and competitive position.
- Evaluate the management team and their track record.
- Understand the risks associated with OTC investing.
- Consult with a financial advisor.
- Monitor trading activity and price volatility.
- Operational history since 2007.
- Development of multiple software solutions.
- Presence in the healthcare and financial services industries.
- Active website and online presence.
Ubiquitech Software Corp. Healthcare Stock: Key Questions Answered
What do analysts say about UBQU stock?
As of 2026-03-17, there is no readily available analyst coverage for Ubiquitech Software Corp. (UBQU) due to its listing on the OTC market and small market capitalization. Investors should conduct their own due diligence and consider the risks associated with investing in OTC stocks. Key valuation metrics, such as the negative P/E ratio, reflect the company's current lack of profitability.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- Financial data is limited due to the company's OTC listing.
- Analyst coverage is not available.